Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Chemical Society Reviews|October 22, 2015
Ferrocifen type anti cancer drugsGérard Jaouen, Anne Vessières, Siden TopDalton Transactions (Cambridge, England : 2003)|January 13, 2006
Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effectsAnne Vessières, Siden Top, Wolfgang Beck, et al.Dalton Transactions (Cambridge, England : 2003)|October 25, 2013
Synthesis and antiproliferative activity of hydroxyferrocifen hybrids against triple-negative breast cancer cellsJosé de Jesús Cázares-Marinero, Siden Top, Anne Vessières, et al.Dalton Transactions (Cambridge, England : 2003)|November 10, 2007
The influence of phenolic hydroxy substitution on the electron transfer and anti-cancer properties of compounds based on the 2-ferrocenyl-1-phenyl-but-1-ene motifElizabeth Anne Hillard, Pascal Pigeon, Anne Vessières, et al.Planta Medica|March 17, 2007
Antiproliferative cardenolides from Periploca graecaDaniela Spera, Tiziana Siciliano, Nunziatina De Tommasi, et al.Current Medicinal Chemistry|September 24, 2004
The first organometallic selective estrogen receptor modulators (SERMs) and their relevance to breast cancerGérard Jaouen, Siden Top, Anne Vessières, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 15, 2022
Modulating undruggable targets to overcome cancer therapy resistanceCatherine Passirani, Anne Vessières, Giuseppe La Regina, et al.Chemmedchem|January 22, 2014
Cytotoxic triosmium carbonyl clusters: a structure-activity relationship studyHui Zhi Shirley Lee, Weng Kee Leong, Siden Top, et al.Chembiochem : a European Journal of Chemical Biology|June 9, 2004
Synthesis of metal-carbonyl-dendrimer-antibody immunoconjugates: towards a new format for carbonyl metallo immunoassayNathalie Fischer-Durand, Michèle Salmain, Bogna Rudolf, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|August 1, 2008
Reactivity and antiproliferative activity of ferrocenyl-tamoxifen adducts with cyclodextrins against hormone-independent breast-cancer cell linesOlivier Buriez, Jan Martin Heldt, Eric Labbé, et al.Pageof 6